CompletedPHASE2, PHASE3NCT06341998

Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children

Studying Tumor of testis and paratestis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shandong First Medical University
Principal Investigator
Jingfu Wang, MD
Shandong Cancer Hospital and Institute
Intervention
sirolimus combined with chemotherapy in the treatment of recurrent/refractory yolk sac tumor in children(drug)
Enrollment
32 enrolled
Eligibility
1-18 years · All sexes
Timeline
2020 – 2024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06341998 on ClinicalTrials.gov

Other trials for Tumor of testis and paratestis

Additional recruiting or active studies for the same condition.

See all trials for Tumor of testis and paratestis →

← Back to all trials